Key facts
| Price (PPV) | 41.10 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | ténoxicam |
| Class | Antiinflammatory and antirheumatic products |
| ATC code | M01AC02 |
| Manufacturer | AFRIC-PHAR |
| Presentation | Boîte de 10 |
| Nature | Médicament |
| Hospital price | 25.70 MAD |
| Data collected on | 9/8/2026 |
Indications
Elles procèdent de l'activité anti-inflammatoire du ténoxicam, de l'importance des manifestations d'intolérance auxquelles le médicament donne lieu et de sa place dans l'éventail des produits anti-inflammatoires actuellement disponibles. Elles sont limitées chez l'adulte et l'enfant à partir de 15 ans au : # Traitement symptomatique au long cours : - des rhumatismes inflammatoires chroniques notamment polyarthrite rhumatoïde, spondylarthrite ankylosante ou syndromes apparentés, tel que le syndrome de Fiessinger - Leroy - Reiter et rhumatisme psoriasique ; - de certaines arthroses douloureuses et invalidantes. # Traitement symptomatique de courte durée des poussées aiguës des : - rhumatismes abarticulaires, tels que périarthrites scapulo-humérales, tendinites, bursites ; - affections aiguës post traumatiques de l'appareil locomoteur ; - arthroses ; - lombo-radiculalgies sévères.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Doxican 20 mg (AFRIC-PHAR) contains the same active substance as Doxican 20 mg (Ténoxicam) at the same strength, but in a different pack: Boîte de 20 at 72.40 MAD, i.e. 3.62 MAD per unit against 4.11 MAD for Doxican 20 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Doxican 20 mg | AFRIC-PHAR | Boîte de 20 | 72.40 MAD | 3.62 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Doxican 20 mg
Doxican 20 mg belongs to the antiinflammatory and antirheumatic products therapeutic class. In Morocco, this drug is marketed by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Doxican 20 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Doxican 20 mg
Answers to common questions from Moroccan patients about this drug.